AARTI DRUGS
Back to Balance Sheet
|
AARTI DRUGS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹837 Cr | ₹796 Cr | ₹949 Cr | ₹940 Cr | ₹595 Cr |
What is the latest Total Current Liabilities ratio of AARTI DRUGS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹837 Cr |
| Mar2024 | ₹796 Cr |
| Mar2023 | ₹949 Cr |
| Mar2022 | ₹940 Cr |
| Mar2021 | ₹595 Cr |
How is Total Current Liabilities of AARTI DRUGS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹837 Cr | 5.21 | |
| Mar2024 | ₹796 Cr | -16.21 | |
| Mar2023 | ₹949 Cr | 1.00 | |
| Mar2022 | ₹940 Cr | 57.90 | |
| Mar2021 | ₹595 Cr | - | |
Compare Total Current Liabilities of peers of AARTI DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI DRUGS | ₹3,766.6 Cr | -1.7% | 9.6% | -19.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
AARTI DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI DRUGS | -1.7% |
9.6% |
-19.5% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses